Business Context and Reporting Period
Concentrix Corporation reported on Form 8-K regarding its proposed combination with Webhelp, a customer-experience solutions provider with operations and client relationships in Europe, Latin America, and Africa. The transaction was announced March 29, 2023; the filing was signed March 31, 2023. This filing does not report quarterly or annual operating results.
Transaction and Key Financial Terms
- Concentrix and its wholly owned subsidiary, OSYRIS S.à r.l., entered into a binding put option with Webhelp stockholders to acquire all outstanding shares of Marnix Lux SA, the parent of Webhelp.
- Consideration is expected to comprise €500 million of cash, subject to adjustment; a €700 million two-year seller note bearing 2% annual interest; 14,861,885 Concentrix common shares; and a contingent right to receive up to 750,000 additional shares if specified conditions are met, including Concentrix stock reaching $170 per share within seven years after closing.
- Concentrix arranged a $5.29 billion, 364-day bridge facility commitment with JPMorgan Chase Bank, consisting of $2.44 billion and $1.85 billion term-bridge tranches and a $1.0 billion revolving tranche. The facility is intended to fund part of the cash purchase price, refinance certain Webhelp and Concentrix debt, fund transaction expenses, and provide post-closing working capital and general corporate liquidity.
- Bridge borrowings would bear interest at adjusted term SOFR plus an initial margin of 1.125% to 2.000%, with the margin increasing by 0.25% at each of 90, 180, and 270 days after closing. Undrawn commitment fees range from 0.125% to 0.300%, depending on the applicable pricing basis.
- The filing does not provide pro forma revenue, profit, cash flow, margins, leverage, liquidity balances, or Webhelp operating metrics.
Material Changes Versus the Prior Comparable Period
The filing text does not provide a prior-period financial comparison. The material development is the proposed acquisition and the related planned issuance of equity and contemplated increase in financing commitments.
- Existing Concentrix stockholders beneficially owning approximately 15.3% of outstanding common stock agreed to support and vote for the transaction and share issuance, subject to the terms of the voting agreement.
- Webhelp sellers will receive significant equity ownership, with specified board nomination, lock-up, and registration rights under the Investor Rights Agreement. GBL may nominate two directors while specified ownership thresholds are met, declining to one or zero directors as ownership decreases.
Guidance, Outlook, Risks, and Contingencies
- Closing was expected before the end of 2023, subject to completion of works council consultations, Concentrix shareholder approval of the share issuance, antitrust and other regulatory clearances, Nasdaq listing approval, and other customary closing conditions.
- The put option expires on the earlier of five business days after the required works council consultations or September 29, 2023. The exclusivity period generally extends until the earlier of SPA execution and March 29, 2024.
- Termination provisions may require expense reimbursement of up to $31 million, increasing to $110 million in specified circumstances, or payment of a $110 million fee in connection with certain termination events.
- Key risks include failure to obtain approvals or financing, adverse credit-market conditions, foreign-exchange movements affecting euro-denominated obligations, integration and employee-retention challenges, failure to realize anticipated synergies, management distraction, client or third-party disruption, litigation, cybersecurity incidents, labor-cost increases, economic conditions, and regulatory or competitive changes.
- The filing contains forward-looking statements regarding transaction timing, financing, the combined company, anticipated benefits, and closing conditions. Management states that it undertakes no duty to update those statements.
Most Important Facts for Investors to Verify
- Whether the works council consultations, shareholder vote, antitrust reviews, regulatory approvals, and Nasdaq listing approval were completed.
- Whether the put option was exercised and the definitive Share Purchase and Contribution Agreement was executed.
- The final cash, seller-note, equity, earnout, and purchase-price-adjustment amounts at closing.
- Whether the $5.29 billion bridge facility was drawn, refinanced, amended, or replaced, and the resulting post-closing leverage and interest expense.
- The final number of Concentrix shares issued, dilution to existing holders, and any earned contingent shares.
- Webhelp’s audited financial information, pro forma combined results, expected synergies, integration costs, and management’s updated outlook.
- Any termination fees, litigation, regulatory conditions, or changes to the transaction terms disclosed in subsequent SEC filings.